Chronic Lymphocytic Leukemia Moon Shot (CLL) update

submitted by: mdanderson

Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. Michael Keating, M.D., professor in Leukemia at MD Anderson Cancer Center and one of the leaders in the CLL Moon Shot, discusses new advances in treating CLL, including alternatives to chemotherapy and using one’s own immune system to fight this disease.

Immunotherapy: unleashing immune system to attack cancer

submitted by: mdanderson
Cancer immunotherapy treats the immune system rather than the tumor. Jim Allison, Ph.D., professor in Immunology at MD Anderson Cancer Center, has developed an innovative approach that will open doors for treating all types of cancer. Padmanee Sharma, M.D., Ph.D., associate professor in Genitourinary Medical Oncology and Immunology, is lead scientist on immunotherapy clinical trials. Listen to Allison and Sharma discuss their collaboration on MD Anderson’s Moon Shots Program to develop...

Leukemia (AML/MDS) Moon Shots update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/leukemia-aml-mds-moon-shots/id431848... . Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world’s largest practice for treating AML and MDS. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson, discusses milestones made with this MD Anderson moon shots,...

Breast and Ovarian Cancers Moon Shot update

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/podcast/breast-ovarian-cancers-moon/id431848... The moon shot for breast and ovarian cancer focuses on two diseases: triple-negative breast cancer and high-grade serous ovarian cancer. Jennifer Litton, M.D., associate professor of Breast Medical Oncology, and Shannon Westin, M.D., assistant professor of Gynecologic and Reproductive Medicine, discuss several new and exciting projects underway that can quickly make a difference in the...

Congenital Heart Defects: Could the Developing Heart Hold the Key to New Therapies?

submitted by: mcgheek

Andrew M. Atz, M.D., Chief of the Division of Pediatric Cardiology at MUSC's Children's Hospital, and Kyu-Ho Lee, M.D., PhD, a developmental biologist at MUSC's Cardiovascular Developmental Biology Center, discuss how better understanding the gene signaling involved in the embryonic development of the heart could lead to new adjunctive therapies for congenital heart defects. Learn more about Dr. Lee's work in the November 2013 issue of Progressnotes at MUSChealth.com/progressnotes

Introduction to story boarding

submitted by: kpezzoli

slides with templates

Proton therapy treatment for glioblastoma

submitted by: mdanderson

Glioblastoma multiforme is one of the toughest brain tumors to treat and also is one of the most aggressive. Paul Brown, M.D., professor in Radiation Oncology at MD Anderson Cancer Center, discusses a ground-breaking clinical trial that treats glioblastoma with intensity modulated proton therapy (IMPT). Also in this podcast, Brown explains other new discoveries in adult and childhood brain cancer research and the importance of a skilled proton therapy center.

Novel cell-based and materials science approach to target Glioblastoma brain cancer tumors

submitted by: nsf

Stefan Bossmann and Deryl Troyer at Kansas State University are developing a novel materials treatment method for persons with brain cancer that uses a type of white blood cell to deliver anticancer drugs to particularly virulent brain tumors.

Smokers with HIV/AIDS find quitting easier with cell phone counseling

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/smokers-hiv-aids-find-quitting/id43... A smoking-cessation intervention delivered through mobile phones to smokers who are HIV/AIDS positive has a better success rate compared to standard treatment. Listen to Ellen Gritz, Ph.D., professor and chair, and Damon Vidrine, Dr.P.H., assistant professor, both in Behavioral Science at MD Anderson Cancer Center, discuss their research findings.

Young breast cancer patients with early-stage disease may undergo unnecessary testing when diagnosed

submitted by: mdanderson
Download from iTunes: https://itunes.apple.com/us/itunes-u/young-breast-cancer-patients/id4318... . More than one third of younger, early stage breast cancer patients undergo unnecessary imaging procedures – including position emission tomography (PET), computed tomography (CT), nuclear medicine bone scans (NMBS) and tumor markers (TM) -- at the time of staging and diagnosis. Carlos Barcenas, M.D., assistant professor, Breast Medical Oncology and Sharon Giordano, M.D., professor, Breast...